title: Radiation-inducible gene therapy.
abstract: The radiation-inducible chimeric genetic construct Egr-TNF alpha introduced into human xenografts produces cytotoxicity of infected tumor cells resulting in tumor growth inhibition. The interaction between Egr-TNF and radiation is selectively cytotoxic for the tumor microvasculature resulting in vascular thrombosis and tumor necrosis. Gene therapy combined with radiation therapy offers great potential for the treatment of localized human cancers.
authors: Department of Radiation and Cellular Oncology, University of Chicago, IL 60637, USA. rrw@rover.uchicago.edu
authors: H J
authors: HJ
authors: Mauceri
authors: N N
authors: NN
authors: Hanna
authors: M J
authors: MJ
authors: Staba
authors: M A
authors: MA
authors: Beckett
authors: D W
authors: DW
authors: Kufe
authors: R R
authors: RR
authors: Weichselbaum
mesh_terms: D000256:Adenoviridae / Q000235:genetics; D004268:DNA-Binding Proteins / Q000235:genetics; D051766:Early Growth Response Protein 1; D005786:Gene Expression Regulation / Q000528:radiation effects*; D018390:Gene Targeting; D015316:Genetic Therapy / Q000379:methods*; D005822:Genetic Vectors; D006801:Humans; D017874:Immediate-Early Proteins / Q000235:genetics*; D014157:Transcription Factors / Q000235:genetics; D014183:Transplantation, Heterologous; D014409:Tumor Necrosis Factor-alpha / Q000627:therapeutic use
chemical_list: D004268:DNA-Binding Proteins; C497325:EGR1 protein, human; D051766:Early Growth Response Protein 1; D017874:Immediate-Early Proteins; D014157:Transcription Factors; D014409:Tumor Necrosis Factor-alpha